Representante de Ventas Línea Cardiometabólico at Eli Lilly and Company

Bogotá, Bogota, Colombia

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Profesionales en áreas administrativas con experiencia en visita médica
Profesionales de la salud (Médicos, Enfermeras, Químicos Farmacéuticos, etc.) con pasión por los pacientes e interés en áreas comerciales y de negocio
Habilidades para el análisis e interpretación de datos y toma de decisiones basadas en información
Conocimiento profundo del Sistema de Salud colombiano (EPS, IPSs, cadena de distribución, estadios de enfermedades, protocolos y guías de tratamiento)
Flexibilidad, adaptación al cambio, actitud ganadora y deseos de desarrollarse en el sector corporativo enfocado en mejorar la vida de los pacientes
Deseable: Nivel de Inglés intermedio y alta comprensión de literatura científica en inglés
Deseable: Experiencia comercial o en la industria farmacéutica

Responsibilities

Conocer a profundidad las bases científicas de los medicamentos innovadores y divulgarlas constantemente con especialistas (Endocrinos, cardiólogos, diabetólogos, internistas, nefrólogos y otros) para beneficiar a los pacientes
Implementar la estrategia de mercadeo y lograr impacto en clientes clave a través de estrategia multicanal
Identificar y direccionar barreras clínicas, administrativas y económicas que dificulten la prescripción o acceso de pacientes a los tratamientos
Construir y establecer relaciones de alta calidad con stakeholders de las instituciones a cargo
Priorizar oportunidades del territorio, elaborar planes de acción y asegurar su implementación para alcanzar objetivos
Conocer y cumplir procesos, políticas y procedimientos de Lilly para mantener altos estándares de cumplimiento y ética

Skills

Sales

Pharmaceuticals

Cardiometabolic

Diabetes

Marketing Strategy

Stakeholder Management

Healthcare Market

Multichannel Strategy

Endocrinology

Cardiology

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free